Advances in Slowing the Progression of CKD with SGLT2 Inhibitors

Dec 15, 2023

1.25

Claim your AMA PRA Category 1 Credit(s) credit

Already have an Account? Log In
Don’t have an account? Register Today

Claim your Certificate

PCSK9 Inhibitors in Primary Prevention: A New Paradigm for Family Physicians

The Evolving Role of High Efficacy, Anti-CD40 Therapeutics for Relapsing Multiple Sclerosi...

Review of Biosimilar Therapeutics for Patients with Relapsing Multiple Sclerosis